bleomycin blm Search Results


91
Proteintech rabbit polyclonal anti blmh
Rabbit Polyclonal Anti Blmh, supplied by Proteintech, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bleomycin+blm/BLMH+Antibody/pmc04601148-316-43-48
Average 91 stars, based on 1 article reviews
rabbit polyclonal anti blmh - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

90
ApexBio bleomycin blm
Bleomycin Blm, supplied by ApexBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bleomycin+blm/bleomycin+blm/pm39489819-70-14-16
Average 90 stars, based on 1 article reviews
bleomycin blm - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Nippon Kayaku blm (300 µg/ml)
Blm (300 µg/Ml), supplied by Nippon Kayaku, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bleomycin+blm/bleomycin++blm/pm25514921-55-22-25
Average 90 stars, based on 1 article reviews
blm (300 µg/ml) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Janvier Labs mouse blm (bleomycine) pulmonary fibrosis model
Mouse Blm (Bleomycine) Pulmonary Fibrosis Model, supplied by Janvier Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bleomycin+blm/mouse+blm++bleomycine++pulmonary+fibrosis+model/us10048250-1043-1-33
Average 90 stars, based on 1 article reviews
mouse blm (bleomycine) pulmonary fibrosis model - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
BioShop bleomycin sulfate blm
Bleomycin Sulfate Blm, supplied by BioShop, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bleomycin+blm/bleomycin+sulfate+blm/10__1128_slash_jvi__05009___11-58-0-6
Average 90 stars, based on 1 article reviews
bleomycin sulfate blm - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Hisun Pharmaceuticals bleomycin blm
Bleomycin Blm, supplied by Hisun Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bleomycin+blm/bleomycin+blm/10__1164_slash_rccm__202110___2414oc-78-5-7
Average 90 stars, based on 1 article reviews
bleomycin blm - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Novartis bleomycin (blm) hydrochloride
Changes in the body weight and lung pathology after tripterine treatment. (A) Changes in the body weight of the mice at different time points. (B) The endpoint weight of the mice in each group. (C) Ashcroft scores in a different group. (D) Haematoxylin-Eosin and Masson staining results of lung sections in a different group. Scale bars: 50 μm. Data are reported in the figures as the mean ± standard deviation, n = 6 in each group. ### p < 0.001 vs the normal group; * p < 0.05, ** p < 0.01, and *** p < 0.001 vs. the <t>BLM-treated</t> group. BLM, <t>bleomycin</t> (5 mg/kg); Trip, tripterine.
Bleomycin (Blm) Hydrochloride, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bleomycin+blm/bleomycin++blm++hydrochloride/pmc09676266-55-18-21
Average 90 stars, based on 1 article reviews
bleomycin (blm) hydrochloride - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Almirall Hermal bleomycin blm bleomycin sulfate
Changes in the body weight and lung pathology after tripterine treatment. (A) Changes in the body weight of the mice at different time points. (B) The endpoint weight of the mice in each group. (C) Ashcroft scores in a different group. (D) Haematoxylin-Eosin and Masson staining results of lung sections in a different group. Scale bars: 50 μm. Data are reported in the figures as the mean ± standard deviation, n = 6 in each group. ### p < 0.001 vs the normal group; * p < 0.05, ** p < 0.01, and *** p < 0.001 vs. the <t>BLM-treated</t> group. BLM, <t>bleomycin</t> (5 mg/kg); Trip, tripterine.
Bleomycin Blm Bleomycin Sulfate, supplied by Almirall Hermal, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bleomycin+blm/bleomycin+blm+bleomycin+sulfate/pmc06113210-156-26-30
Average 90 stars, based on 1 article reviews
bleomycin blm bleomycin sulfate - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
GlpBio Technology Inc bleomycin sulfate blm
Changes in the body weight and lung pathology after tripterine treatment. (A) Changes in the body weight of the mice at different time points. (B) The endpoint weight of the mice in each group. (C) Ashcroft scores in a different group. (D) Haematoxylin-Eosin and Masson staining results of lung sections in a different group. Scale bars: 50 μm. Data are reported in the figures as the mean ± standard deviation, n = 6 in each group. ### p < 0.001 vs the normal group; * p < 0.05, ** p < 0.01, and *** p < 0.001 vs. the <t>BLM-treated</t> group. BLM, <t>bleomycin</t> (5 mg/kg); Trip, tripterine.
Bleomycin Sulfate Blm, supplied by GlpBio Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bleomycin+blm/bleomycin+sulfate+blm/pm37257706-60-0-7
Average 90 stars, based on 1 article reviews
bleomycin sulfate blm - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Huirui Pharmacy Co Ltd bleomycin blm
MECP2 expression was increased in lung and BALF samples from IPF patients and mice with pulmonary fibrosis. (a) Western blotting analysis of MECP2 expression in the lung homogenates derived from IPF patients and control subjects. Left panel: Representative Western blotting images. Right panel: A bar graph showing the mean data of all subjects analyzed in each group. (b) Representative images for single‐cell sequencing from two IPF patients. (c and d) Representative results of coimmunostaining for MECP2 and CD68 in lung sections (c) and BALF (d) from IPF patients and control subjects. A total of five patients with IPF and five control subjects were analyzed. (e and f) Representative coimmunostaining results showing Mecp2 and CD68 in BALF (e) and lung sections (f) from <t>BLM‐induced</t> mice with pulmonary fibrosis. The nuclei were stained blue by DAPI, and the images were taken at ×400 magnification. Five mice were included in each study group. * p < 0.05; ** p < 0.01; *** p < 0.001. BALF, bronchoalveolar lavage fluid; BLM, <t>bleomycin;</t> IPF, idiopathic pulmonary fibrosis; MECP2, methyl‐CpG‐binding protein 2
Bleomycin Blm, supplied by Huirui Pharmacy Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bleomycin+blm/bleomycin+blm/pmc09115697-50-0-5
Average 90 stars, based on 1 article reviews
bleomycin blm - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Bristol Myers bleomycin (blm) sulphate
MECP2 expression was increased in lung and BALF samples from IPF patients and mice with pulmonary fibrosis. (a) Western blotting analysis of MECP2 expression in the lung homogenates derived from IPF patients and control subjects. Left panel: Representative Western blotting images. Right panel: A bar graph showing the mean data of all subjects analyzed in each group. (b) Representative images for single‐cell sequencing from two IPF patients. (c and d) Representative results of coimmunostaining for MECP2 and CD68 in lung sections (c) and BALF (d) from IPF patients and control subjects. A total of five patients with IPF and five control subjects were analyzed. (e and f) Representative coimmunostaining results showing Mecp2 and CD68 in BALF (e) and lung sections (f) from <t>BLM‐induced</t> mice with pulmonary fibrosis. The nuclei were stained blue by DAPI, and the images were taken at ×400 magnification. Five mice were included in each study group. * p < 0.05; ** p < 0.01; *** p < 0.001. BALF, bronchoalveolar lavage fluid; BLM, <t>bleomycin;</t> IPF, idiopathic pulmonary fibrosis; MECP2, methyl‐CpG‐binding protein 2
Bleomycin (Blm) Sulphate, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bleomycin+blm/bleomycin++blm++sulphate/pm25927611-84-1-7
Average 90 stars, based on 1 article reviews
bleomycin (blm) sulphate - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
PanReac AppliChem bleomycin blm
MECP2 expression was increased in lung and BALF samples from IPF patients and mice with pulmonary fibrosis. (a) Western blotting analysis of MECP2 expression in the lung homogenates derived from IPF patients and control subjects. Left panel: Representative Western blotting images. Right panel: A bar graph showing the mean data of all subjects analyzed in each group. (b) Representative images for single‐cell sequencing from two IPF patients. (c and d) Representative results of coimmunostaining for MECP2 and CD68 in lung sections (c) and BALF (d) from IPF patients and control subjects. A total of five patients with IPF and five control subjects were analyzed. (e and f) Representative coimmunostaining results showing Mecp2 and CD68 in BALF (e) and lung sections (f) from <t>BLM‐induced</t> mice with pulmonary fibrosis. The nuclei were stained blue by DAPI, and the images were taken at ×400 magnification. Five mice were included in each study group. * p < 0.05; ** p < 0.01; *** p < 0.001. BALF, bronchoalveolar lavage fluid; BLM, <t>bleomycin;</t> IPF, idiopathic pulmonary fibrosis; MECP2, methyl‐CpG‐binding protein 2
Bleomycin Blm, supplied by PanReac AppliChem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bleomycin+blm/bleomycin+blm/pm29709612-46-0-14
Average 90 stars, based on 1 article reviews
bleomycin blm - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Changes in the body weight and lung pathology after tripterine treatment. (A) Changes in the body weight of the mice at different time points. (B) The endpoint weight of the mice in each group. (C) Ashcroft scores in a different group. (D) Haematoxylin-Eosin and Masson staining results of lung sections in a different group. Scale bars: 50 μm. Data are reported in the figures as the mean ± standard deviation, n = 6 in each group. ### p < 0.001 vs the normal group; * p < 0.05, ** p < 0.01, and *** p < 0.001 vs. the BLM-treated group. BLM, bleomycin (5 mg/kg); Trip, tripterine.

Journal: Frontiers in Pharmacology

Article Title: Connective tissue disease-related interstitial lung disease is alleviated by tripterine through inhibition of the PI3K/Akt, apoptosis, and TNF-α signalling pathways

doi: 10.3389/fphar.2022.990760

Figure Lengend Snippet: Changes in the body weight and lung pathology after tripterine treatment. (A) Changes in the body weight of the mice at different time points. (B) The endpoint weight of the mice in each group. (C) Ashcroft scores in a different group. (D) Haematoxylin-Eosin and Masson staining results of lung sections in a different group. Scale bars: 50 μm. Data are reported in the figures as the mean ± standard deviation, n = 6 in each group. ### p < 0.001 vs the normal group; * p < 0.05, ** p < 0.01, and *** p < 0.001 vs. the BLM-treated group. BLM, bleomycin (5 mg/kg); Trip, tripterine.

Article Snippet: The following were the reagents and instruments used in this study: tripterine (Shanghai Yuanye Bio-Technology Co., Ltd, China); bleomycin (BLM) hydrochloride (Novartis Pharma AG, BASEL, Switzerland); anti-collagens I and III, anti-vimentin, and anti-α-smooth muscle actin (SMA) (Servicebio Technology Co., Ltd, China); anti-phosphatidylinositol-3-kinase (PI3K), anti-phospho-PI3K, anti-protein kinase B (Akt), and anti-phospho-Akt (Abmart, Shanghai, China) antibodies; anti-β-actin (Proteintech Group Inc., China); mouse tumour necrosis factor-α kit and mouse hydroxyproline kit (Nanjing Jiancheng Biotechnology Co., Ltd, China); terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labelling (TUNEL) apoptosis assay kit (Beyotime Biotechnology Co., Ltd, China).

Techniques: Staining, Standard Deviation

Deposition of collagen I and III and micro-computed tomography (CT) findings in mouse lungs. (A) Collagen I and III depositions in the lung tissues of mice after tripterine treatment. (B) Micro-CT findings of the lungs in mice treated with tripterine. Scale bars: 50 μm. Results are presented as the mean ± standard error of the mean. ### p < 0.001 vs the normal group; * p < 0.05, ** p < 0.01, and *** p < 0.001 vs. the BLM-treated group. BLM, bleomycin (5 mg/kg); Trip, tripterine.

Journal: Frontiers in Pharmacology

Article Title: Connective tissue disease-related interstitial lung disease is alleviated by tripterine through inhibition of the PI3K/Akt, apoptosis, and TNF-α signalling pathways

doi: 10.3389/fphar.2022.990760

Figure Lengend Snippet: Deposition of collagen I and III and micro-computed tomography (CT) findings in mouse lungs. (A) Collagen I and III depositions in the lung tissues of mice after tripterine treatment. (B) Micro-CT findings of the lungs in mice treated with tripterine. Scale bars: 50 μm. Results are presented as the mean ± standard error of the mean. ### p < 0.001 vs the normal group; * p < 0.05, ** p < 0.01, and *** p < 0.001 vs. the BLM-treated group. BLM, bleomycin (5 mg/kg); Trip, tripterine.

Article Snippet: The following were the reagents and instruments used in this study: tripterine (Shanghai Yuanye Bio-Technology Co., Ltd, China); bleomycin (BLM) hydrochloride (Novartis Pharma AG, BASEL, Switzerland); anti-collagens I and III, anti-vimentin, and anti-α-smooth muscle actin (SMA) (Servicebio Technology Co., Ltd, China); anti-phosphatidylinositol-3-kinase (PI3K), anti-phospho-PI3K, anti-protein kinase B (Akt), and anti-phospho-Akt (Abmart, Shanghai, China) antibodies; anti-β-actin (Proteintech Group Inc., China); mouse tumour necrosis factor-α kit and mouse hydroxyproline kit (Nanjing Jiancheng Biotechnology Co., Ltd, China); terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labelling (TUNEL) apoptosis assay kit (Beyotime Biotechnology Co., Ltd, China).

Techniques: Micro-CT

Effects of tripterine on epithelial-mesenchymal transformation markers of lung tissue in the connective tissue disease-related interstitial lung disease (CTD-ILD) model mice. (A) α -smooth muscle actin (SMA) and vimentin of lung tissues were analysed by Western blotting. (B) Expression changes in α -SMA and vimentin in the lung tissues of the mice were analysed by densitometry. (C) The hydroxyproline content in the lung tissues of the mice was determined by enzyme-linked immunosorbent assay. (D) Immunohistochemistry analysis of α -SMA and vimentin expression levels in the lung tissues of mice treated with tripterine. Scale bars: 50 μm. Data reported in the figures are presented as the mean ± standard deviation, n = 6 in each group. ### p < 0.001 vs. the normal group; * p < 0.05, ** p < 0.01, and *** p < 0.001 vs. the BLM-treated group. BLM, bleomycin (5 mg/kg); Trip, tripterine.

Journal: Frontiers in Pharmacology

Article Title: Connective tissue disease-related interstitial lung disease is alleviated by tripterine through inhibition of the PI3K/Akt, apoptosis, and TNF-α signalling pathways

doi: 10.3389/fphar.2022.990760

Figure Lengend Snippet: Effects of tripterine on epithelial-mesenchymal transformation markers of lung tissue in the connective tissue disease-related interstitial lung disease (CTD-ILD) model mice. (A) α -smooth muscle actin (SMA) and vimentin of lung tissues were analysed by Western blotting. (B) Expression changes in α -SMA and vimentin in the lung tissues of the mice were analysed by densitometry. (C) The hydroxyproline content in the lung tissues of the mice was determined by enzyme-linked immunosorbent assay. (D) Immunohistochemistry analysis of α -SMA and vimentin expression levels in the lung tissues of mice treated with tripterine. Scale bars: 50 μm. Data reported in the figures are presented as the mean ± standard deviation, n = 6 in each group. ### p < 0.001 vs. the normal group; * p < 0.05, ** p < 0.01, and *** p < 0.001 vs. the BLM-treated group. BLM, bleomycin (5 mg/kg); Trip, tripterine.

Article Snippet: The following were the reagents and instruments used in this study: tripterine (Shanghai Yuanye Bio-Technology Co., Ltd, China); bleomycin (BLM) hydrochloride (Novartis Pharma AG, BASEL, Switzerland); anti-collagens I and III, anti-vimentin, and anti-α-smooth muscle actin (SMA) (Servicebio Technology Co., Ltd, China); anti-phosphatidylinositol-3-kinase (PI3K), anti-phospho-PI3K, anti-protein kinase B (Akt), and anti-phospho-Akt (Abmart, Shanghai, China) antibodies; anti-β-actin (Proteintech Group Inc., China); mouse tumour necrosis factor-α kit and mouse hydroxyproline kit (Nanjing Jiancheng Biotechnology Co., Ltd, China); terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labelling (TUNEL) apoptosis assay kit (Beyotime Biotechnology Co., Ltd, China).

Techniques: Transformation Assay, Western Blot, Expressing, Enzyme-linked Immunosorbent Assay, Immunohistochemistry, Standard Deviation

Effects of tripterine on phosphatidylinositol-3-kinase (PI3K)/protein kinase B (Akt) and tumour necrosis factor (TNF)-α expression levels. (A) PI3K/Akt-related protein expression in lung tissues was detected by Western blotting. (B) Densitometry analysis of PI3K/Akt protein expression. Scale bars: 50 μm. Data are presented as the mean ± standard deviation (SD), n = 3. (C) TNF-α expression in the lung homogenate and serum of mice were detected by enzyme-linked immunosorbent assay. Data are presented as the mean ± SD, n = 6. ### p < 0.001 vs. the normal group; * p < 0.05, ** p < 0.01, and *** p < 0.001 vs. the BLM-treated group. BLM, bleomycin (5 mg/kg); Trip, tripterine.

Journal: Frontiers in Pharmacology

Article Title: Connective tissue disease-related interstitial lung disease is alleviated by tripterine through inhibition of the PI3K/Akt, apoptosis, and TNF-α signalling pathways

doi: 10.3389/fphar.2022.990760

Figure Lengend Snippet: Effects of tripterine on phosphatidylinositol-3-kinase (PI3K)/protein kinase B (Akt) and tumour necrosis factor (TNF)-α expression levels. (A) PI3K/Akt-related protein expression in lung tissues was detected by Western blotting. (B) Densitometry analysis of PI3K/Akt protein expression. Scale bars: 50 μm. Data are presented as the mean ± standard deviation (SD), n = 3. (C) TNF-α expression in the lung homogenate and serum of mice were detected by enzyme-linked immunosorbent assay. Data are presented as the mean ± SD, n = 6. ### p < 0.001 vs. the normal group; * p < 0.05, ** p < 0.01, and *** p < 0.001 vs. the BLM-treated group. BLM, bleomycin (5 mg/kg); Trip, tripterine.

Article Snippet: The following were the reagents and instruments used in this study: tripterine (Shanghai Yuanye Bio-Technology Co., Ltd, China); bleomycin (BLM) hydrochloride (Novartis Pharma AG, BASEL, Switzerland); anti-collagens I and III, anti-vimentin, and anti-α-smooth muscle actin (SMA) (Servicebio Technology Co., Ltd, China); anti-phosphatidylinositol-3-kinase (PI3K), anti-phospho-PI3K, anti-protein kinase B (Akt), and anti-phospho-Akt (Abmart, Shanghai, China) antibodies; anti-β-actin (Proteintech Group Inc., China); mouse tumour necrosis factor-α kit and mouse hydroxyproline kit (Nanjing Jiancheng Biotechnology Co., Ltd, China); terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labelling (TUNEL) apoptosis assay kit (Beyotime Biotechnology Co., Ltd, China).

Techniques: Expressing, Western Blot, Standard Deviation, Enzyme-linked Immunosorbent Assay

The apoptosis level of the lung tissues was analysed by immunofluorescence. Normal: normal group; BLM, bleomycin (5 mg/kg); scale bars: 100 μm.

Journal: Frontiers in Pharmacology

Article Title: Connective tissue disease-related interstitial lung disease is alleviated by tripterine through inhibition of the PI3K/Akt, apoptosis, and TNF-α signalling pathways

doi: 10.3389/fphar.2022.990760

Figure Lengend Snippet: The apoptosis level of the lung tissues was analysed by immunofluorescence. Normal: normal group; BLM, bleomycin (5 mg/kg); scale bars: 100 μm.

Article Snippet: The following were the reagents and instruments used in this study: tripterine (Shanghai Yuanye Bio-Technology Co., Ltd, China); bleomycin (BLM) hydrochloride (Novartis Pharma AG, BASEL, Switzerland); anti-collagens I and III, anti-vimentin, and anti-α-smooth muscle actin (SMA) (Servicebio Technology Co., Ltd, China); anti-phosphatidylinositol-3-kinase (PI3K), anti-phospho-PI3K, anti-protein kinase B (Akt), and anti-phospho-Akt (Abmart, Shanghai, China) antibodies; anti-β-actin (Proteintech Group Inc., China); mouse tumour necrosis factor-α kit and mouse hydroxyproline kit (Nanjing Jiancheng Biotechnology Co., Ltd, China); terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labelling (TUNEL) apoptosis assay kit (Beyotime Biotechnology Co., Ltd, China).

Techniques: Immunofluorescence

MECP2 expression was increased in lung and BALF samples from IPF patients and mice with pulmonary fibrosis. (a) Western blotting analysis of MECP2 expression in the lung homogenates derived from IPF patients and control subjects. Left panel: Representative Western blotting images. Right panel: A bar graph showing the mean data of all subjects analyzed in each group. (b) Representative images for single‐cell sequencing from two IPF patients. (c and d) Representative results of coimmunostaining for MECP2 and CD68 in lung sections (c) and BALF (d) from IPF patients and control subjects. A total of five patients with IPF and five control subjects were analyzed. (e and f) Representative coimmunostaining results showing Mecp2 and CD68 in BALF (e) and lung sections (f) from BLM‐induced mice with pulmonary fibrosis. The nuclei were stained blue by DAPI, and the images were taken at ×400 magnification. Five mice were included in each study group. * p < 0.05; ** p < 0.01; *** p < 0.001. BALF, bronchoalveolar lavage fluid; BLM, bleomycin; IPF, idiopathic pulmonary fibrosis; MECP2, methyl‐CpG‐binding protein 2

Journal: Bioengineering & Translational Medicine

Article Title: Macrophage‐targeted delivery of siRNA to silence Mecp2 gene expression attenuates pulmonary fibrosis

doi: 10.1002/btm2.10280

Figure Lengend Snippet: MECP2 expression was increased in lung and BALF samples from IPF patients and mice with pulmonary fibrosis. (a) Western blotting analysis of MECP2 expression in the lung homogenates derived from IPF patients and control subjects. Left panel: Representative Western blotting images. Right panel: A bar graph showing the mean data of all subjects analyzed in each group. (b) Representative images for single‐cell sequencing from two IPF patients. (c and d) Representative results of coimmunostaining for MECP2 and CD68 in lung sections (c) and BALF (d) from IPF patients and control subjects. A total of five patients with IPF and five control subjects were analyzed. (e and f) Representative coimmunostaining results showing Mecp2 and CD68 in BALF (e) and lung sections (f) from BLM‐induced mice with pulmonary fibrosis. The nuclei were stained blue by DAPI, and the images were taken at ×400 magnification. Five mice were included in each study group. * p < 0.05; ** p < 0.01; *** p < 0.001. BALF, bronchoalveolar lavage fluid; BLM, bleomycin; IPF, idiopathic pulmonary fibrosis; MECP2, methyl‐CpG‐binding protein 2

Article Snippet: Bleomycin (BLM) was obtained from Huirui.

Techniques: Expressing, Western Blot, Derivative Assay, Control, Sequencing, Staining, Binding Assay

Biodistribution of liposomes after intratracheal injection. (a) Schematic diagram showing the preparation of Mecp2 siRNA‐loaded liposomes. (b) Representative TEM image of Mecp2 siRNA‐loaded liposomes. (c) Hydrodynamic diameter distributions of Mecp2 siRNA‐loaded liposomes. (d) Colloid stability of siRNA‐loaded liposomes in PBS. (e) Representative IVIS images of a mouse at different time points after the administration of DiR‐labeled liposomes. (f) Ex vivo fluorescence images of major organs from mice. (g) Immunofluorescence image showing the biodistribution of DiR‐labeled liposomes (red) in the lungs of BLM‐induced mice. The nuclei were stained blue by DAPI, and the images were taken at ×400 magnification. (h) Flow cytometric analysis of liposomes distribution in the lungs of BLM‐induced mice. (i) Temporal changes in Mecp2 expression in the lungs of Mecp2 siRNA‐loaded liposomes transfected mice after 14 days of BLM induction. Five mice were included in each study group. *** p < 0.001. BLM, bleomycin; Mecp2, methyl‐CpG‐binding protein 2; PBS, phosphate‐buffered saline; siRNA, small interfering RNA; TEM, transmission electron microscopy

Journal: Bioengineering & Translational Medicine

Article Title: Macrophage‐targeted delivery of siRNA to silence Mecp2 gene expression attenuates pulmonary fibrosis

doi: 10.1002/btm2.10280

Figure Lengend Snippet: Biodistribution of liposomes after intratracheal injection. (a) Schematic diagram showing the preparation of Mecp2 siRNA‐loaded liposomes. (b) Representative TEM image of Mecp2 siRNA‐loaded liposomes. (c) Hydrodynamic diameter distributions of Mecp2 siRNA‐loaded liposomes. (d) Colloid stability of siRNA‐loaded liposomes in PBS. (e) Representative IVIS images of a mouse at different time points after the administration of DiR‐labeled liposomes. (f) Ex vivo fluorescence images of major organs from mice. (g) Immunofluorescence image showing the biodistribution of DiR‐labeled liposomes (red) in the lungs of BLM‐induced mice. The nuclei were stained blue by DAPI, and the images were taken at ×400 magnification. (h) Flow cytometric analysis of liposomes distribution in the lungs of BLM‐induced mice. (i) Temporal changes in Mecp2 expression in the lungs of Mecp2 siRNA‐loaded liposomes transfected mice after 14 days of BLM induction. Five mice were included in each study group. *** p < 0.001. BLM, bleomycin; Mecp2, methyl‐CpG‐binding protein 2; PBS, phosphate‐buffered saline; siRNA, small interfering RNA; TEM, transmission electron microscopy

Article Snippet: Bleomycin (BLM) was obtained from Huirui.

Techniques: Liposomes, Injection, Labeling, Ex Vivo, Fluorescence, Immunofluorescence, Staining, Expressing, Transfection, Binding Assay, Saline, Small Interfering RNA, Transmission Assay, Electron Microscopy

Intratracheal administration of Mecp2 siRNA‐loaded liposomes reversed established pulmonary fibrosis. (a) Schematic of the experimental design. (b) Histological analysis of the severity of lung fibrosis in mice after BLM induction. Left panel: Representative images of H&E‐ (top), Masson‐ (middle), and Sirius red (bottom)‐stained lung sections. Images were taken at an original magnification of ×200. (c) Ashcroft scores showing the severity of fibrosis. (d) The quantification of hydroxyproline in BLM‐induced mice. (e) Western blotting analysis of fibronectin, collagen 1, α‐SMA, and Mecp2 expression in mice. Left panel: Representative Western blotting images. Right panel: Bar graphs showing the mean data from all subjects analyzed in each group. (f–i) RT‐PCR analysis of Fn1 (f), Col1a1 (j), Acta2 (h), and Mecp2 (i) expression in each group. Five mice were included in each study group. * p < 0.05; ** p < 0.01; *** p < 0.001. BLM, bleomycin; H&E, hematoxylin and eosin; Mecp2, methyl‐CpG‐binding protein 2; RT‐PCR, reverse transcription‐polymerase chain reaction; siRNA, small interfering RNA

Journal: Bioengineering & Translational Medicine

Article Title: Macrophage‐targeted delivery of siRNA to silence Mecp2 gene expression attenuates pulmonary fibrosis

doi: 10.1002/btm2.10280

Figure Lengend Snippet: Intratracheal administration of Mecp2 siRNA‐loaded liposomes reversed established pulmonary fibrosis. (a) Schematic of the experimental design. (b) Histological analysis of the severity of lung fibrosis in mice after BLM induction. Left panel: Representative images of H&E‐ (top), Masson‐ (middle), and Sirius red (bottom)‐stained lung sections. Images were taken at an original magnification of ×200. (c) Ashcroft scores showing the severity of fibrosis. (d) The quantification of hydroxyproline in BLM‐induced mice. (e) Western blotting analysis of fibronectin, collagen 1, α‐SMA, and Mecp2 expression in mice. Left panel: Representative Western blotting images. Right panel: Bar graphs showing the mean data from all subjects analyzed in each group. (f–i) RT‐PCR analysis of Fn1 (f), Col1a1 (j), Acta2 (h), and Mecp2 (i) expression in each group. Five mice were included in each study group. * p < 0.05; ** p < 0.01; *** p < 0.001. BLM, bleomycin; H&E, hematoxylin and eosin; Mecp2, methyl‐CpG‐binding protein 2; RT‐PCR, reverse transcription‐polymerase chain reaction; siRNA, small interfering RNA

Article Snippet: Bleomycin (BLM) was obtained from Huirui.

Techniques: Liposomes, Staining, Western Blot, Expressing, Reverse Transcription Polymerase Chain Reaction, Binding Assay, Reverse Transcription, Polymerase Chain Reaction, Small Interfering RNA

Mecp2 enhanced M2 polarization in BLM‐induced mice. (a) Flow cytometric analysis of M2 macrophages in the lung from each group. Upper panel: Scatter diagrams showing the flow cytometric analysis. Lower panel: A bar graph showing the data. CD206 and CD11c cells were gated from the F4/80 + cells. (b) Western blotting analysis of CD206, Ym1 and Arg1 expression in mice. Left panel: Representative Western blotting images. Right panel: Bar graphs showing the data from five mice. * p < 0.05; ** p < 0.01; *** p < 0.001. Arg1, Arginase 1; BLM, bleomycin; Mecp2, methyl‐CpG‐binding protein 2; Ym1, chitinase 3‐like 3

Journal: Bioengineering & Translational Medicine

Article Title: Macrophage‐targeted delivery of siRNA to silence Mecp2 gene expression attenuates pulmonary fibrosis

doi: 10.1002/btm2.10280

Figure Lengend Snippet: Mecp2 enhanced M2 polarization in BLM‐induced mice. (a) Flow cytometric analysis of M2 macrophages in the lung from each group. Upper panel: Scatter diagrams showing the flow cytometric analysis. Lower panel: A bar graph showing the data. CD206 and CD11c cells were gated from the F4/80 + cells. (b) Western blotting analysis of CD206, Ym1 and Arg1 expression in mice. Left panel: Representative Western blotting images. Right panel: Bar graphs showing the data from five mice. * p < 0.05; ** p < 0.01; *** p < 0.001. Arg1, Arginase 1; BLM, bleomycin; Mecp2, methyl‐CpG‐binding protein 2; Ym1, chitinase 3‐like 3

Article Snippet: Bleomycin (BLM) was obtained from Huirui.

Techniques: Western Blot, Expressing, Binding Assay

Therapeutic effect of Mecp2 siRNA‐loaded liposomes on pulmonary fibrosis was depend on macrophages. (a) Schematic of the experimental design. (b) Histological analysis of the severity of lung fibrosis in mice after BLM induction. Left panel: Representative images of H&E‐ (left), Masson‐ (middle), and Sirius red (right)‐stained lung sections. Images were taken at an original magnification of ×200. (c) Ashcroft scores showing the severity of fibrosis. (d) The quantification of hydroxyproline in BLM‐induced mice. (e) Western blotting analysis of fibronectin, collagen 1, α‐SMA, and Mecp2 expression in mice. Left panel: Representative Western blotting images. Right panel: Bar graph showing the mean data from all subjects analyzed in each group. (f) RT‐PCR analysis of Fn1 , Col1a1 , and Acta2 expression in each group. Four mice were included in each study group. BLM, bleomycin; H&E, hematoxylin and eosin; Mecp2, methyl‐CpG‐binding protein 2; RT‐PCR, reverse transcription‐polymerase chain reaction; siRNA, small interfering RNA

Journal: Bioengineering & Translational Medicine

Article Title: Macrophage‐targeted delivery of siRNA to silence Mecp2 gene expression attenuates pulmonary fibrosis

doi: 10.1002/btm2.10280

Figure Lengend Snippet: Therapeutic effect of Mecp2 siRNA‐loaded liposomes on pulmonary fibrosis was depend on macrophages. (a) Schematic of the experimental design. (b) Histological analysis of the severity of lung fibrosis in mice after BLM induction. Left panel: Representative images of H&E‐ (left), Masson‐ (middle), and Sirius red (right)‐stained lung sections. Images were taken at an original magnification of ×200. (c) Ashcroft scores showing the severity of fibrosis. (d) The quantification of hydroxyproline in BLM‐induced mice. (e) Western blotting analysis of fibronectin, collagen 1, α‐SMA, and Mecp2 expression in mice. Left panel: Representative Western blotting images. Right panel: Bar graph showing the mean data from all subjects analyzed in each group. (f) RT‐PCR analysis of Fn1 , Col1a1 , and Acta2 expression in each group. Four mice were included in each study group. BLM, bleomycin; H&E, hematoxylin and eosin; Mecp2, methyl‐CpG‐binding protein 2; RT‐PCR, reverse transcription‐polymerase chain reaction; siRNA, small interfering RNA

Article Snippet: Bleomycin (BLM) was obtained from Huirui.

Techniques: Liposomes, Staining, Western Blot, Expressing, Reverse Transcription Polymerase Chain Reaction, Binding Assay, Reverse Transcription, Polymerase Chain Reaction, Small Interfering RNA